| Products | Business Development | News | Contact |
|
||
Management
Kevin FitzGerald
Chief Executive Officer
Managing Director
Prior to joining f-star, Dr Kevin FitzGerald was CEO and a main board member of Isogenica Ltd. which he founded in 2000. Before establishing Isogenica, Kevin was a member of the senior management team at Actinova Ltd., the UK subsidiary of Active Biotech AB. Prior to this Kevin spent seven years at Cambridge Antibody Technology plc. (acquired by AstraZeneca in 2006) where he was among the founding group of scientists.
Kevin studied for his PhD in the laboratory of Sir Greg Winter FRS at the MRC Laboratory of Molecular Biology, Cambridge and for his MBA at Aston Business School following receipt of a Sainsbury Management Fellowship from the Royal Academy of Engineering, London. Kevin was elected a fellow of the Royal Society of Medicine in 2006.
Kevin Moulder
Chief Scientific Officer
Kevin has a PhD in medical immunology from the University of London and
did a post doctoral fellowship at the National Institutes of Health,
Maryland, USA. Early on in his career Kevin was group leader at
SmithKline Beecham (Epsom, UK), and Director Experimental Therapeutics
at Ares-Serono (Randolph, Massachusetts, USA). Kevin spent six years at
Biogen (Boston, Massachusetts, USA - now Biogen-Idec) heading up the
Bioassay and Predictive Medicine departments in Medical Research. At
Biogen he was also product development team leader for the Antova
program and CMC presenter to the FDA and EMEA for Amevive. After Biogen,
Kevin returned to the UK as Vice President, R&D and subsequently Vice
President of Development for Domantis (Cambridge UK) and before joining
F-Star Kevin had two short tenures at Modern Biosciences (London) and
Molecular Partners (Zurich).
Kevin has extensive experience of the discovery processes as well as
proven success in managing preclinical programs, regulatory submissions
and Phase 1 and 2 clinical trials.